Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
28
Number of overlapping holdings
46.7%
% of XLV's 60 holdings also in BMED
26.7%
% of BMED's 115 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in BMED |
Overlap | |
|---|---|---|---|---|
 |
INTUITIVE SURGICAL INC | 3.5% | 4.9% | 3.5% |
|
ABBVIE INC | 6.2% | 3.1% | 3.1% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 4.9% | 2.8% |
|
ABBOTT LABORATORIES | 4.6% | 2.7% | 2.7% |
|
GILEAD SCIENCES INC | 2.6% | 3.7% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to BMED
|
ELI LILLY & CO | 13.4% |
|
UNITEDHEALTH GROUP INC | 8.5% |
|
JOHNSON & JOHNSON | 7.7% |
|
MERCK & CO. INC. | 4.0% |
|
ABBVIE INC | 3.1% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
|
ELEVANCE HEALTH INC | 2.0% |
|
ABBOTT LABORATORIES | 1.9% |
|
THERMO FISHER SCIENTIFIC INC | 1.9% |
|
CIGNA CORPORATION | 1.8% |
XLV Underweight Relative to BMED
 |
ROCHE HOLDING AG-BR | -3.4% |
 |
ARGENX SE ADR | -3.3% |
|
LONZA GROUP AG-REG | -2.7% |
|
UCB SA | -2.2% |
|
REPLIGEN CORP | -2.1% |
|
BOSTON SCIENTIFIC CORP | -2.1% |
|
WATERS CORP | -1.7% |
|
BIO-TECHNE CORPORATION | -1.6% |
|
NEUROCRINE BIOSCIENCES INC | -1.5% |
|
NATERA INC | -1.5% |